Levosimendan | 14 (11.6%) | 2 (4.0%) | 0.118 | |
IABP insertion | 21 (17.5%) | 3 (6.0%) | 0.049* | |
Superficial wound infection | 11 (9.1%) | 4 (8.0%) | 0.806 | |
Cerebrovascular events | 6 (5.0%) | 1 (2.0%) | 0.369 | |
MI | 20 (16.6%) | 5 (10.0%) | 0.263 | |
Non-fatal MI | 13 (10.8%) | 4 (8.0%) | 0.574 | |
Non-fatal cerebrovascular events | 5 (4.1%) | 1 (2.0%) | 0.015* | |
Readmission for HF | 5 (4.1%) | 1 (2.0%) | 0.015* | |
30-days mortality | 10 (8.3%) | 1 (2.0%) | 0.126 | |
Post-operative NYHA class | I | 61 (55.4%) | 29 (59.2%) |
|
II | 42 (38.2%) | 18 (36.7%) | 0.813 | |
III | 7 (6.4%) | 2 (4.1%) |
| |
Postoperative CCS grade | I | 70 (63.6%) | 31 (63.3%) |
|
II | 38 (34.6%) | 17 (34.7%) | 0.995 | |
III | 2 (1.8%) | 1 (2.0%) |
| |
Postoperative LVEDD (cm) | 5.67 ± 0.49 | 5.40 ± 0.54 | 0.007* | |
Postoperative LVESD (cm) | 4.43 ± 0.68 | 3.44 ± 0.57 | 0.002* | |
Postoperative EF (cm) | 38.98 ± 8.50 | 59.44 ± 6.88 | <0.001* | |
30-days mortality | 10 (8.3%) | 1 (2.0%) | 0.126 | |
LIMA = left internal mammary artery, RIMA = right internal mammary artery, SV = Saphenous vein, CPB = cardiopulmonary bypass, ACC = aortic cross-clamp, DC = defibrillating cardiac, ICU = intensive care unit, IABP = intra-aortic balloon pump, MI = Myocardial infection, HF = Heart failure, NYHA = New York Heart Association, CCS = Canadian cardiovascular society, EF = ejection fraction, LVEDD = left ventricular end diastolic diameter, LVESD = left ventricular end systolic diameter. |